---
title: "Hong Kong stock movement: GUIXIN GROUP plummets 20.52%"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/261182735.md"
description: "GUIXIN GROUP fell 20.52%; Longpan Technology rose 0.26%, with a transaction volume of HKD 65.4 million; China Xuyang Group fell 1.27%, with a transaction volume of HKD 8.72 million; Shanghai Petroleum and Chemical Company had a transaction volume of HKD 6.84 million; Li Auto rose 1.68%, with a market value of HKD 3.985 billion"
datetime: "2025-10-15T05:56:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/261182735.md)
  - [en](https://longbridge.com/en/news/261182735.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/261182735.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/261182735.md) | [English](https://longbridge.com/en/news/261182735.md)


# Hong Kong stock movement: GUIXIN GROUP plummets 20.52%

**Hong Kong Stock Movement**

**Stocks with High Trading Volume in the Industry**

Longpan Technology rose 0.26%. There has been no significant news recently; trading is active, and capital flow is evident. Considering the sector and industry trends, this stock shows significant volatility, and the specific reasons need further observation.

Shanghai Petrochemical Company, with a trading volume of HKD 6.84 million. There has been no significant news recently; trading is active, and capital flow is evident. Considering the sector and industry trends, this stock shows significant volatility, and the specific reasons need further observation

### 相關股票

- [GUIXIN GROUP (08349.HK)](https://longbridge.com/zh-HK/quote/08349.HK.md)

## 相關資訊與研究

- [CICC Sticks to Its Buy Rating for C&D International Investment Group Ltd. (1908)](https://longbridge.com/zh-HK/news/280899096.md)
- [Osl Group FY adjusted non-IFRS income HK$534.1 million](https://longbridge.com/zh-HK/news/281223382.md)
- [GF Securities Unveils Audited 2025 Results and Confirms Cash Dividend Payout](https://longbridge.com/zh-HK/news/281031946.md)
- [CSPC Pharmaceutical, Alphamab Oncology's Breast Cancer Drug Study Meets Primary Endpoint](https://longbridge.com/zh-HK/news/281325910.md)
- [Hua Hong Semiconductor Wins SSE Acceptance for Share-Issuance Acquisition Plan](https://longbridge.com/zh-HK/news/281182290.md)